Product image of Metypred (Methylprednisolone) supplied by GNH India

Metypred

Active Ingredient:
Methylprednisolone
Origin:
EU

Metypred (Methylprednisolone)

Methylprednisolone, the active ingredient in Metypred, is a corticosteroid presented as an oral tablet for oral use. It is employed to reduce inflammation and modify immune responses in a range of autoimmune and allergic conditions.

GNH India supplies Metypred as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metypred, a glucocorticoid, is used to manage inflammatory and immune‑mediated disorders.

  • Rheumatoid arthritis: decreases joint inflammation and pain, improving mobility.
  • Asthma: suppresses airway inflammation, helping to prevent bronchospasm.
  • Allergic reactions: reduces swelling, itching and hives caused by allergens.
  • Dermatitis: alleviates skin inflammation and redness.
  • Multiple sclerosis exacerbations: limits neurologic inflammation during flare‑ups.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and alters gene transcription. This modulates the production of inflammatory cytokines, reduces leukocyte migration, and suppresses immune cell activation, resulting in potent anti‑inflammatory and immunosuppressive effects.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Increased appetite: may lead to weight gain.
  • Insomnia: difficulty falling or staying asleep.
  • Mood changes: irritability or euphoria.
  • Hyperglycemia: elevated blood sugar levels.
  • Gastrointestinal discomfort: nausea or dyspepsia.
  • Fluid retention: mild swelling of ankles or feet.

Serious or Rare Side Effects

  • Adrenal suppression: reduced endogenous cortisol production.
  • Severe infection: heightened risk of bacterial, viral or fungal infections.
  • Osteoporosis: loss of bone density with long‑term use.
  • Cataracts or glaucoma: eye pressure changes.
  • Psychosis: severe mood or thought disturbances.
  • Anaphylaxis: rare but life‑threatening allergic reaction.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess infection risk: avoid use in active systemic infections.
  • Monitor blood glucose: patients with diabetes may need dose adjustments.
  • Screen for osteoporosis: consider calcium and vitamin D supplementation.
  • Taper when discontinuing: abrupt cessation can cause adrenal crisis.
  • Avoid concomitant systemic fungal therapy: increased risk of opportunistic infections.
  • Store at room temperature: keep in the original pack, protect from moisture and heat.

Avoid Interactions

Methylprednisolone can interact with several drug classes; awareness helps prevent complications.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors: may increase steroid levels and toxicity.
  • Live vaccines: risk of uncontrolled infection due to immunosuppression.
  • Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive gastrointestinal ulcer risk.
  • Diabetes medications: may require dose adjustments for hyperglycemia.
  • Antihypertensives: possible reduction in blood pressure control.

Frequently Asked Questions

Metypred contains methylprednisolone, a glucocorticoid that is prescribed for inflammatory and immune‑mediated conditions such as rheumatoid arthritis, asthma, allergic reactions, dermatitis, and multiple sclerosis exacerbations. It works by dampening the body’s inflammatory response, helping to relieve symptoms and prevent disease progression.

Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that moves into the cell nucleus. This complex influences gene transcription, decreasing the production of pro‑inflammatory cytokines and reducing immune cell activity, which together produce strong anti‑inflammatory and immunosuppressive effects.

The appropriate dose of Metypred is determined by the prescribing healthcare professional based on the specific condition, severity, patient age, weight, and response to therapy. Dosage regimens can vary widely, and patients should follow the exact instructions provided by their prescriber.

The safety of methylprednisolone in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Pregnant or nursing patients should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the Metypred product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Metypred (methylprednisolone) is a synthetic glucocorticoid with a potency intermediate between prednisolone and dexamethasone. Compared with prednisolone, it often provides a stronger anti‑inflammatory effect at equivalent doses, while having a shorter half‑life than dexamethasone, which may be advantageous for tapering.

Metypred should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain product stability throughout its shelf life.

Metypred is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include adrenal suppression, severe infections, osteoporosis, cataracts or glaucoma, and rare psychiatric effects such as psychosis. Patients should be monitored regularly for signs of these complications, especially during long‑term therapy or high‑dose regimens.

Metypred is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, and in those with systemic fungal infections. Caution is also advised for individuals with uncontrolled diabetes, active viral infections, or severe osteoporosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT